Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00415-020-10069-1 http://scihub22266oqcxt.onion/10.1007/s00415-020-10069-1 32691235!7370633!32691235     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32691235.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       J+Neurol 2021 ; 268 (2): 403-408 Nephropedia Template TP {{tp|p=32691235|t=2021. Impact of the COVID-19 outbreak on acute stroke care |pdf=|usr=}}{{32691235}} gab.com Text Impact of the COVID-19 outbreak on acute stroke care JO: J Neurol http://www.kidney.de/pget.php?&tw=1&pmid=32691235 #FOAvip BACKGROUND AND PURPOSE: There are concerns that the coronavirus disease 2019 (COVID-19) outbreak negatively affects the quality of care for acute cardiovascular conditions. We assessed the impact of the COVID-19 outbreak on trends in hospital admissions and workflow parameters of acute stroke care in Amsterdam, The Netherlands. METHODS: We used data from the three hospitals that provide acute stroke care for the Amsterdam region. We compared two 7-week periods: one during the peak of the COVID-19 outbreak (March 16th-May 3th 2020) and one prior to the outbreak (October 21st-December 8th 2019). We included consecutive patients who presented to the emergency departments with a suspected stroke and assessed the change in number of patients as an incidence-rate ratio (IRR) using a Poisson regression analysis. Other outcomes were the IRR for stroke subtypes, change in use of reperfusion therapy, treatment times, and in-hospital complications. RESULTS: During the COVID-19 period, 309 patients presented with a suspected stroke compared to 407 patients in the pre-COVID-19 period (IRR 0.76 95%CI 0.65-0.88). The proportion of men was higher during the COVID-19 period (59% vs. 47%, p < 0.001). There was no change in the proportion of stroke patients treated with intravenous thrombolysis (28% vs. 30%, p = 0.58) or endovascular thrombectomy (11% vs 12%, p = 0.82) or associated treatment times. Seven patients (all ischemic strokes) were diagnosed with COVID-19. CONCLUSION: We observed a 24% decrease in suspected stroke presentations during the COVID-19 outbreak, but no evidence for a decrease in quality of acute stroke care. Twit Text FOAVip Impact of the COVID-19 outbreak on acute stroke care ????J Neurol http://www.kidney.de/pget.php?&tw=1&pmid=32691235 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32691235 #FOAvip English Wikipedia <ref>{{Cite pmid|32691235}}</ref> Impact of the COVID-19 outbreak on acute stroke care #MMPMID32691235 Rinkel LA; Prick JCM; Slot RER; Sombroek NMA; Burggraaff J; Groot AE; Emmer BJ; Roos YBWEM; Brouwer MC; van den Berg-Vos RM; Majoie CBLM; Beenen LFM; van de Beek D; Visser MC; van Schaik SM; Coutinho JM J Neurol 2021[Feb]; 268 (2): 403-408 PMID32691235show ga BACKGROUND AND PURPOSE: There are concerns that the coronavirus disease 2019 (COVID-19) outbreak negatively affects the quality of care for acute cardiovascular conditions. We assessed the impact of the COVID-19 outbreak on trends in hospital admissions and workflow parameters of acute stroke care in Amsterdam, The Netherlands. METHODS: We used data from the three hospitals that provide acute stroke care for the Amsterdam region. We compared two 7-week periods: one during the peak of the COVID-19 outbreak (March 16th-May 3th 2020) and one prior to the outbreak (October 21st-December 8th 2019). We included consecutive patients who presented to the emergency departments with a suspected stroke and assessed the change in number of patients as an incidence-rate ratio (IRR) using a Poisson regression analysis. Other outcomes were the IRR for stroke subtypes, change in use of reperfusion therapy, treatment times, and in-hospital complications. RESULTS: During the COVID-19 period, 309 patients presented with a suspected stroke compared to 407 patients in the pre-COVID-19 period (IRR 0.76 95%CI 0.65-0.88). The proportion of men was higher during the COVID-19 period (59% vs. 47%, p < 0.001). There was no change in the proportion of stroke patients treated with intravenous thrombolysis (28% vs. 30%, p = 0.58) or endovascular thrombectomy (11% vs 12%, p = 0.82) or associated treatment times. Seven patients (all ischemic strokes) were diagnosed with COVID-19. CONCLUSION: We observed a 24% decrease in suspected stroke presentations during the COVID-19 outbreak, but no evidence for a decrease in quality of acute stroke care. |*COVID-19/epidemiology[MESH] |*Pandemics[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Emergency Medical Services[MESH] |Female[MESH] |Hospitalization[MESH] |Humans[MESH] |Incidence[MESH] |Ischemic Stroke/complications/epidemiology[MESH] |Male[MESH] |Middle Aged[MESH] |Netherlands/epidemiology[MESH] |Poisson Distribution[MESH] |Quality of Health Care[MESH] |Reperfusion[MESH] |Retrospective Studies[MESH] |Stroke/complications/epidemiology/*therapy[MESH] |Thrombectomy/statistics & numerical data[MESH] |Thrombolytic Therapy/statistics & numerical data[MESH] |Time-to-Treatment[MESH]Impact of the COVID-19 outbreak on acute stroke care (epmc).pdf DeepDyve Pubget Overpricing